C07K 14/605
Glucagons
C07K14/605 (Glucagons) appears on 896 US grants and 1,602 published applications in this corpus.
Search patents in C07K- Granted patents
- 896
- Published applications
- 1,602
- Assignees
- 515
- Inventors
- 2,674
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 5 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 7 | 0 |
| 1997 | 7 | 0 |
| 1998 | 7 | 0 |
| 1999 | 13 | 0 |
| 2000 | 9 | 0 |
| 2001 | 12 | 6 |
| 2002 | 15 | 8 |
| 2003 | 13 | 29 |
| 2004 | 5 | 28 |
| 2005 | 8 | 19 |
| 2006 | 12 | 38 |
| 2007 | 19 | 29 |
| 2008 | 13 | 41 |
| 2009 | 21 | 45 |
| 2010 | 17 | 43 |
| 2011 | 25 | 58 |
| 2012 | 30 | 58 |
| 2013 | 31 | 72 |
| 2014 | 48 | 69 |
| 2015 | 47 | 89 |
| 2016 | 47 | 70 |
| 2017 | 50 | 76 |
| 2018 | 54 | 57 |
| 2019 | 55 | 86 |
| 2020 | 40 | 81 |
| 2021 | 60 | 60 |
| 2022 | 41 | 106 |
| 2023 | 49 | 119 |
| 2024 | 30 | 113 |
| 2025 | 51 | 102 |
| 2026 | 42 | 100 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Incretin analogs and uses thereof22 Sep 2026US 12,741,999 B2Eli Lilly and Company
- Polypeptide derivative having dual receptor agonistic action and use thereof15 Sep 2026US 12,735,467 B2Tianjin Institute of Pharmaceutical Research
- Fusion protein having triple activity and use thereof8 Sep 2026US 12,729,231 B2Shanghai Minwei Biotechnology Co., LTD
- Preparation method for semaglutide25 Aug 2026US 12,715,900 B2Shenzhen Jymed Technology Co., Ltd.
- Process for preparing a GIP/GLP1 dual agonist25 Aug 2026US 12,715,901 B2Eli Lilly and Company
- Fgf21 compound / glp-1r agonist combinations with optimized activity ratio8 Oct 2026US 2026/0306587 A1Sanofi
- Method for genetically encoding 2-aminoisobutyric acid and its analogs and applications thereof8 Oct 2026US 2026/0308223 A1Edipro Pharmaceutical Technology Inc.
- Glucagon-like peptide-1 receptor agonist variants and methods thereof1 Oct 2026US 2026/0295054 A1
- Glp-1r/gipr/gcgr triple agonist analogue and use thereof1 Oct 2026US 2026/0295055 A1Shenzhen Bay Laboratory
- Multi-Agonist and Use Thereof1 Oct 2026US 2026/0297154 A1The United Bio-Technology (Hengqin) Co., Ltd.
Most cited
By later US patents
- GLP-1 analogs useful for diabetes treatment380US 5,545,618 A1996
- Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity273US 6,191,102 B1Eli Lilly and Company · 2001
- Insulinotropic hormone271US 5,118,666 AThe General Hospital Corporation · 1992
- Insulinotropic hormone GLP-1 (7-36) and uses thereof270US 5,614,492 AThe General Hospital Corporation · 1997
- Insulinotropic hormone253US 5,120,712 AThe General Hospital Corporation · 1992